Four great radiopharmaceutical companies already trust BIOEMTECH technology for imaging their alpha-emitters and not only!
Very recently our team was in Oslo, for installing one more γ-eye at ARTBIO. The previous one was in Boston for our collaborators at Ratio Therapeutics. Before that we were in Ohio and Perspective Therapeutics and it all started with Texas and our friends at Radiomedix, Inc.
Although most radiopharma companies subcontract their preclinical studies, there is a lot of work that needs and can be done in house; Having the ability to in vivo screen easily and fast, multiple compounds at the earliest possible development stage can save a tremendous amount of time and resources.
And the greatest reward is to see them publishing such data, as Radiomedix, Inc. did at WMIC24, Ratio Therapeutics will do at EANM24 and Perspective Therapeutics is doing in multiple conferences, TRP meetings and recent papers.